Octreotide Acetate Pen 25000 mcg, 7000 mcg Suppliers & Bulk Manufacturers
Available Forms: injection (prefilled syringe)
Available Strengths: 25000 mcg, 7000 mcg
Reference Brands: Bynfezia Pen (USA)
Category: Oncology Cancer Care
Octreotide (brand Sandostatin®) is used to treat carcinoid tumors, acromegaly, and GEP-NETs. Available in subcutaneous injections (0.5 mg/mL, 1 mg/mL, 3 mg/mL) and long-acting formulations (Sandostatin LAR®) (10 mg, 20 mg, 30 mg), it controls tumor-related symptoms like diarrhea and flushing by inhibiting hormone release. Available through GMP-compliant suppliers in the US and EU for oncology treatment.
Product Description:
Octreotide, marketed under the brand name Sandostatin®, is a somatostatin analogue used in oncology to manage carcinoid tumors, acromegaly, and gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Available as subcutaneous injections (0.5 mg/mL, 1 mg/mL, 3 mg/mL) and long-acting injections (Sandostatin LAR®) (10 mg, 20 mg, 30 mg), it works by inhibiting hormone secretion, controlling tumor-induced symptoms like diarrhea and flushing. Sourced from GMP-certified suppliers, Octreotide is widely available for global distribution in US and EU markets. It provides reliable therapeutic options for oncologists and healthcare providers treating complex neuroendocrine tumors.
Octreotide Acetate Pen — third party manufacturing & bulk supply
Octreotide Acetate Pen 25000 mcg, 7000 mcg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Octreotide Acetate Pen listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Octreotide Acetate Pen →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Octreotide acetate pen is used for the management of acromegaly to suppress excess growth hormone secretion, treatment of symptoms caused by neuroendocrine tumors (such as flushing and diarrhea), and control of severe diarrhea and flushing associated with carcinoid syndrome. The pen delivers precise subcutaneous doses of octreotide acetate for symptomatic control in chronic conditions requiring long-term therapy.
Octreotide acetate pen contains octreotide acetate, a synthetic octapeptide analog of somatostatin formulated for subcutaneous injection. It mimics the action of natural somatostatin by inhibiting the release of growth hormone and certain gastrointestinal hormones.
A known trade name for the octreotide acetate prefilled injection pen is Bynfezia® Pen (availability may vary by market).
The octreotide acetate pen (e.g., Bynfezia® Pen) is manufactured and marketed by Novartis Pharmaceuticals or its affiliates, depending on the regional distribution agreements and licensing arrangements.
The generic name of the product is octreotide acetate.
The brand name of the octreotide acetate pen is Bynfezia® Pen.
Octreotide acetate pen is manufactured in GMP-compliant pharmaceutical facilities in countries including the USA and Europe, depending on regulatory approvals and local supply chains.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
